KLTO Klotho Neurosciences, Inc.
Healthcare$0.38+0.00%OpenMarket Cap: $20.1M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.99
P/S
0.00
EV/EBITDA
-2.95
DCF Value
$-0.01
FCF Yield
-20.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-137.6%
ROA
-110.0%
ROIC
-75.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $0.00 | NaN% | $-1.9M | $-2.9M | $— | — |
| Q2 null | $0.00 | NaN% | $-1.9M | $-4.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-1.6M | $-2.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-1.9M | $-2.1M | $— | — |
| FY null | $0.00 | NaN% | $-5.5M | $-6.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-2.9M | $-3.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-395.6K | $-451.6K | $— | — |
| Q1 null | $0.00 | NaN% | $-672.0K | $-672.0K | $— | — |
| Q4 null | $0.00 | NaN% | $-110.7K | $-126.5K | $— | — |
| FY null | $0.00 | NaN% | $-631.3K | $-707.5K | $— | — |
| Q3 2023 | $0.00 | NaN% | $-123.7K | $-144.1K | $-0.00 | — |
| Q2 2023 | $0.00 | NaN% | $-244.3K | $-264.4K | $-0.02 | — |